# Study to Assess Safety, Tolerability and Pharmacokinetics After Single Doses of AZD2516 to Healthy Volunteers

> **NCT00754715** · PHASE1 · COMPLETED · sponsor: **AstraZeneca** · enrollment: 72 (estimated)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** AZD2516
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00754715
- **Lead sponsor:** AstraZeneca
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-09
- **Primary completion:** 2008-11
- **Final completion:** 2008-12
- **Target enrollment:** 72 (ESTIMATED)
- **Last updated:** 2008-12-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00754715

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00754715, "Study to Assess Safety, Tolerability and Pharmacokinetics After Single Doses of AZD2516 to Healthy Volunteers". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00754715. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*